Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Wiegele, M; Schöchl, H; Haushofer, A; Ortler, M; Leitgeb, J; Kwasny, O; Beer, R; Ay, C; Schaden, E.
Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement.
Crit Care. 2019; 23(1): 62-62.
Doi: 10.1186/s13054-019-2352-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Haushofer Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- There is a high degree of uncertainty regarding optimum care of patients with potential or known intake of oral anticoagulants and traumatic brain injury (TBI). Anticoagulation therapy aggravates the risk of intracerebral hemorrhage but, on the other hand, patients take anticoagulants because of an underlying prothrombotic risk, and this could be increased following trauma. Treatment decisions must be taken with due consideration of both these risks. An interdisciplinary group of Austrian experts was convened to develop recommendations for best clinical practice. The aim was to provide pragmatic, clear, and easy-to-follow clinical guidance for coagulation management in adult patients with TBI and potential or known intake of platelet inhibitors, vitamin K antagonists, or non-vitamin K antagonist oral anticoagulants. Diagnosis, coagulation testing, and reversal of anticoagulation were considered as key steps upon presentation. Post-trauma management (prophylaxis for thromboembolism and resumption of long-term anticoagulation therapy) was also explored. The lack of robust evidence on which to base treatment recommendations highlights the need for randomized controlled trials in this setting.
- Find related publications in this database (using NLM MeSH Indexing)
- Administration, Oral -
- Anticoagulants - adverse effects
- Anticoagulants - therapeutic use
- Anticoagulants -
- Brain Injuries, Traumatic - drug therapy
- Brain Injuries, Traumatic - physiopathology
- Consensus -
- Dabigatran - adverse effects
- Dabigatran - therapeutic use
- Deamino Arginine Vasopressin - pharmacology
- Humans -
- Interdisciplinary Communication -
- Partial Thromboplastin Time - methods
- Pyrazoles - analysis
- Pyrazoles - blood
- Pyrazoles - therapeutic use
- Pyridines - analysis
- Pyridines - blood
- Pyridines - therapeutic use
- Pyridones - analysis
- Pyridones - blood
- Pyridones - therapeutic use
- Rivaroxaban - analysis
- Rivaroxaban - blood
- Rivaroxaban - therapeutic use
- Thiazoles - analysis
- Thiazoles - blood
- Thiazoles - therapeutic use
- Thromboembolism - prevention & control
- Tomography, X-Ray Computed - methods
- Tranexamic Acid - therapeutic use
- Treatment Outcome -
- Vitamin K - antagonists & inhibitors
- Vitamin K - therapeutic use
- Find related publications in this database (Keywords)
- Anticoagulation reversal
- Coagulation management
- Idarucizumab
- Intracranial hemorrhage
- Non-vitamin K antagonist oral anticoagulant (NOAC)
- Platelet inhibitors
- Prothrombin complex concentrate (PCC)
- Traumatic brain injury
- Vitamin K antagonist (VKA)